Dyadic International Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$0.78

+0.01 (+0.65%)

As of Aug 15, 2:28 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 6 86%

Hold 1 14%

Sell 0 0%

Price Target

Analyst Price Target +4,111.1% upside

Low Target $20.70

Average Target $32.64

High Target $34.69

Current Price $0.78

Current
$0.78

Target
$32.64

$20.70 $32.64 avg $34.69

Scenario Analysis

Bear Case

$20.70

2,570.6%

Low target

Base Case

$32.64

+4,111.1%

Avg target

Bull Case

$34.69

+4,375.6%

High target

Risk/Reward

1.7x

Balanced

Price in Context

52-Week High

$1.60

-51.6% from high

52-Week Low

$0.65

+18.4% from low

Target vs 52W High

$32.64

+1,940.0% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	38	82%	$257.58	+3.3%
AMGN Amgen Inc	Hold	43	49%	$190.87	-54.0%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+162.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	37	81%	$438.34	-13.3%
REGN Regeneron Pharmaceuticals	Buy	37	70%	$76.80	-90.4%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-53.9%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-44.0%
BIIB Biogen Inc	Buy	43	67%	$91.45	-56.4%